Tharimmune makes $540M bet on Canton Coin in crypto treasury push
The biotech company's pivot into digital assets marks one of the largest treasury financings to date, underscoring growing institutional demand for tokenized finance.
Archive context
Older archive item. Useful for background and entity history, but not a fresh market-moving signal.
The biotech company's pivot into digital assets marks one of the largest treasury financings to date, underscoring growing institutional demand for tokenized finance.
Why this matters
This cryptocurrency story adds another data point to the current market tape and is useful when read alongside nearby source coverage.
Original source
Read on CointelegraphRelated market context
BlackRock’s digital assets chief to speak at Bitcoin Treasuries Conference in New York City
BlackRock's involvement signals growing institutional interest in Bitcoin, potentially influencing corporate strategies and market...
KULR Technology sells remaining 764 Bitcoin for $59M, fully exits crypto treasury strategy
KULR's exit from crypto reflects a strategic pivot towards core business investments, highlighting the volatility and risk of cryp...
Strategy prioritizes $950 million STRC buyback over expanding its Bitcoin treasury
Strategy’s latest $139.3 million repurchase of STRC variable-rate preferred shares has brought its spending on buybacks to about $...
Strive buys additional 469 Bitcoin, pushing total holdings to 25,000 BTC
Strive's Bitcoin strategy, funded via preferred stock, risks treasury value compression if Bitcoin prices fall, impacting financia...
Morgan Stanley reiterates Bitcoin’s digital gold thesis in new research
Morgan Stanley's endorsement of Bitcoin as digital gold may accelerate institutional adoption, influencing portfolio diversificati...
Strive adds 469 Bitcoin to reach 25,000 BTC treasury
Strive’s latest Bitcoin purchase was funded entirely through its SATA preferred stock as the company continues its rapid climb amo...